Think CLEAR
Think SOOLANTRA ® ^
^Overall rosacea severity classified as ‘ clear ’ is defined as achieving IGA 0 . SOOLANTRA ® increases the likelihood of patients achieving ‘ clear ’ ( IGA 0 ) results vs metronidazole at 16 weeks ( 34.9 % vs 21.7 %) 3 , 4 * * P-value not reported
Not an actual patient . Digitally adapted to IGA 0 . Individual results may vary .
Not an actual patient . Image has been digitally altered to represent a patient advanced in their journey towards clear skin .
Not an actual patient . Digitally adapted to IGA 4 . Individual results may vary .
For the topical treatment of Acne Vulgaris of the face and / or the trunk in patients from 12 years of age and older1
For the topical treatment of inflammatory lesions of Rosacea ( papulopustular ) in adult patients4
PBS INFORMATION : Aklief ® ( 0.005 % Trifarotene Cream ) is not listed on the PBS .
Please review the Full Product Information before prescribing , available via the QR code .
PBS INFORMATION : Soolantra ® ( Ivermectin Cream ) product is not listed on the PBS .
Please review the Full Product Information before prescribing , available via the QR code .
References : 1 . Aklief Prescribing information . 2 . Cosio T , et al . Biomedicines . 2021 ; 9:237 . 3 . Taieb A , et al . Br J Dermatol . 2015 ; 172 ( 4 ): 1103 – 1110 . 4 . SOOLANTRA ® Approved Product Information . ® Registered trademark of Galderma Australia Pty Ltd . ABN 12 003 976 930 . Level 18 , 1 Denison St , North Sydney , NSW 2060 , Australia . Phone : 1800 800 765 . Date of preparation : April 2024 . AU-AFC-2400006 . FR10932 .